Commentary: Health disparities across the cancer care continuum and implications for microsimulation modeling.
Commentary: Health disparities across the cancer care continuum and implications for microsimulation modeling.
复制标题
评论:整个癌症护理过程中的健康差异以及对微观模拟模型的影响。
DOI:
10.1093/jncimonographs/lgad031
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Winn,RobertA
中科院分区:
文献类型:
--
作者:
Doubeni,ChykeA;Bailey,ZinziD;Winn,RobertA
Cancer health disparities are measurable remediable, but persistent, differences in cancer-related quality of life or mortality across groups of people. Health disparities are rooted in historical injustices, including systemic racism (1), which, in turn, create inequities in risk exposures and access to and quality of health services (2-4).In this issue of the Journal, Cancer Intervention and Surveillance Modeling Network (CISNET) researchers collaborated on population simulation models to evaluate how interventions across the cancer care continuum contribute to mortality disparities between Black people and the overall US population (Figure 1). Across racial and ethnic groups currently defined in Surveillance, Epidemiology, and End Results Program data, Black people have the highest cancer mortality rate and the Asian and Pacific Islander group the lowest (5). Encouragingly, the overall US cancer mortality rate declined by 33% from 1991 to 2020 (4, 5), with improvements across all racial and ethnic groups along with the narrowing of the gap across groups, overall and among cancers with a Grade A or B screening recommendation from the US Preventive Services Task Force (USPSTF)(Figure 1)(5). However, the progress is heterogenous across cancer sites; mortality disparities are largest for lung and smallest for cervical cancer (5). Nonetheless, these trends are promising and point to opportunities to optimize care along the cancer care continuum (Figure 2). Further, evidence on eliminating disparities between Black and White people in both incidence and mortality for colorectal cancer using sustained, coordinated efforts across the cancer care continuum is a strong catalyst for future progress (6).
影响因子:
29.4
作者:
Doubeni CA;Fedewa SA;Levin TR;Jensen CD;Saia C;Zebrowski AM;Quinn VP;Rendle KA;Zauber AG;Becerra-Culqui TA;Mehta SJ;Fletcher RH;Schottinger J;Corley DA
通讯作者:
Corley DA
影响因子:
2.6
作者:
McKenna, Claire
通讯作者:
McKenna, Claire
影响因子:
254.7
作者:
Siegel, Rebecca L.;Miller, Kimberly D.;Jemal, Ahmedin
通讯作者:
Jemal, Ahmedin